<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epilepsia Open</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia Open</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2470-9239</journal-id>
<journal-id journal-id-type="publisher-id">EPI4</journal-id>
<journal-title-group>
<journal-title>Epilepsia Open</journal-title>
</journal-title-group>
<issn pub-type="epub">2470-9239</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29588953</article-id>
<article-id pub-id-type="pmc">5719854</article-id>
<article-id pub-id-type="doi">10.1002/epi4.12057</article-id>
<article-id pub-id-type="publisher-id">EPI412057</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Full‐Length Original Research</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Full‐length Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Copy number variation in a hospital‐based cohort of children with epilepsy</article-title>
<alt-title alt-title-type="left-running-head">D. R. M. Vlaskamp et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="epi412057-cr-0001">
<name>
<surname>Vlaskamp</surname>
<given-names>Danique R. M.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6820-8268</contrib-id>
<xref ref-type="aff" rid="epi412057-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="epi412057-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="bio" rid="epi412057-biog-0001">*</xref>
</contrib>
<contrib contrib-type="author" id="epi412057-cr-0002">
<name>
<surname>Callenbach</surname>
<given-names>Petra M. C.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2447-7746</contrib-id>
<xref ref-type="aff" rid="epi412057-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="epi412057-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="epi412057-cr-0003">
<name>
<surname>Rump</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="epi412057-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="epi412057-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="epi412057-cr-0004">
<name>
<surname>Giannini</surname>
<given-names>Lucia A. A.</given-names>
</name>
<xref ref-type="aff" rid="epi412057-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="epi412057-cr-0005">
<name>
<surname>Dijkhuizen</surname>
<given-names>Trijnie</given-names>
</name>
<xref ref-type="aff" rid="epi412057-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="epi412057-cr-0006">
<name>
<surname>Brouwer</surname>
<given-names>Oebele F.</given-names>
</name>
<xref ref-type="aff" rid="epi412057-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="epi412057-cr-0007">
<name>
<surname>van Ravenswaaij‐Arts</surname>
<given-names>Conny M. A.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8744-1305</contrib-id>
<address>
<email>c.m.a.van.ravenswaaij@umcg.nl</email>
</address>
<xref ref-type="aff" rid="epi412057-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="epi412057-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Departments of Neurology</named-content>
<named-content content-type="organisation-division">University Medical Center Groningen</named-content>
<institution>University of Groningen</institution>
<named-content content-type="city">Groningen</named-content>
<country country="NL">the Netherlands</country>
</aff>
<aff id="epi412057-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Genetics</named-content>
<named-content content-type="organisation-division">University Medical Center Groningen</named-content>
<institution>University of Groningen</institution>
<named-content content-type="city">Groningen</named-content>
<country country="NL">the Netherlands</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Address correspondence to Conny M. A. van Ravenswaaij‐Arts, Department of Genetics, University Medical Center Groningen, University of Groningen, CB50, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E‐mail: <email>c.m.a.van.ravenswaaij@umcg.nl</email></corresp>
<fn fn-type="equal" id="epi412057-note-1001">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2017</year>
</pub-date>
<volume>2</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1002/epi4.2017.2.issue-2</issue-id>
<fpage>244</fpage>
<lpage>254</lpage>
<history>
<date date-type="accepted">
<day>24</day>
<month>3</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 International League Against Epilepsy <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The Authors. <italic>Epilepsia Open</italic> published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution‐NonCommercial‐NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EPI4-2-244.pdf" xlink:type="simple"></self-uri>
<abstract id="epi412057-abs-0001">
<title>Summary</title>
<sec id="epi412057-sec-0001">
<title>Objective</title>
<p>To evaluate the diagnostic yield of microarray analysis in a hospital‐based cohort of children with seizures and to identify novel candidate genes and susceptibility loci for epilepsy.</p>
</sec>
<sec id="epi412057-sec-0002">
<title>Methods</title>
<p>Of all children who presented with their first seizure in the University Medical Center Groningen (January 2000 through May 2013) (n = 1,368), we included 226 (17%) children who underwent microarray analysis before June 2014. All 226 children had a definite diagnosis of epilepsy. All their copy number variants (<styled-content style="fixed-case">CNV</styled-content>s) on chromosomes 1–22 and X that contain protein‐coding genes and have a prevalence of &lt;1% in healthy controls were evaluated for their pathogenicity.</p>
</sec>
<sec id="epi412057-sec-0003">
<title>Results</title>
<p>Children selected for microarray analysis more often had developmental problems (82% vs. 25%, p &lt; 0.001), facial dysmorphisms (49% vs. 8%, p &lt; 0.001), or behavioral problems (41% vs. 13%, p &lt; 0.001) than children who were not selected. We found known clinically relevant <styled-content style="fixed-case">CNV</styled-content>s for epilepsy in 24 of the 226 children (11%). Seventeen of these 24 children had been diagnosed with symptomatic focal epilepsy not otherwise specified (71%) and five with West syndrome (21%). Of these 24 children, many had developmental problems (100%), behavioral problems (54%) or facial dysmorphisms (46%). We further identified five novel <styled-content style="fixed-case">CNV</styled-content>s comprising four potential candidate genes for epilepsy: <italic><styled-content style="fixed-case">MYT</styled-content>1L, <styled-content style="fixed-case">UNC</styled-content>5D, <styled-content style="fixed-case">SCN</styled-content>4B,</italic> and <italic><styled-content style="fixed-case">NRXN</styled-content>3</italic>.</p>
</sec>
<sec id="epi412057-sec-0004">
<title>Significance</title>
<p>The 11% yield in our hospital‐based cohort underscores the importance of microarray analysis in diagnostic evaluation of children with epilepsy.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="epi412057-kwd-0001">Microarray</kwd>
<kwd id="epi412057-kwd-0002">Deletions</kwd>
<kwd id="epi412057-kwd-0003">Duplications</kwd>
<kwd id="epi412057-kwd-0004">Genetics</kwd>
<kwd id="epi412057-kwd-0005">Seizures</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>UCB Pharma BV</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="4"></table-count>
<page-count count="11"></page-count>
<word-count count="7009"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>epi412057</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.5 mode:remove_FC converted:17.11.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>
<boxed-text content-type="box" id="epi412057-blkfxd-0001" orientation="portrait" position="anchor"><caption><title>Key Points</title></caption><p>
<list id="epi412057-list-0001" list-type="bullet"><list-item><p>Microarray in our hospital‐based cohort of children with epilepsy had a 11% yield of clinically relevant CNVs</p></list-item><list-item><p>The yield of microarray in children with epilepsy is largely based on the selection of individuals by the clinician</p></list-item><list-item><p>Novel CNVs were identified, including four epilepsy candidate genes: <italic>MYT1L, UNC5D, SCN4B,</italic> and <italic>NRXN3</italic>
</p></list-item></list>
</p></boxed-text>
</p>
<sec id="epi412057-sec-0006">
<p>Genetic factors play an important role in the etiology of epilepsy,<xref ref-type="ref" rid="epi412057-bib-0001">1</xref> as demonstrated by the large number of genes and regions that cause or predispose to epilepsy newly identified by various genome‐wide technologies.<xref ref-type="ref" rid="epi412057-bib-0002">2</xref> Chromosomal microarray analysis, in particular, enables the identification of chromosomal deletions (losses) or duplications (gains), called copy number cariants (CNVs).<xref ref-type="ref" rid="epi412057-bib-0003">3</xref> CNVs may contribute to epilepsy in two ways. First, CNVs that include epilepsy‐related genes could lead to epilepsy following a Mendelian inheritance. For example, both <italic>KCNQ2</italic> sequence variants and whole gene deletions can cause benign familial neonatal seizures.<xref ref-type="ref" rid="epi412057-bib-0004">4</xref>, <xref ref-type="ref" rid="epi412057-bib-0005">5</xref> Second, CNVs that occur more frequently in patients compared to in healthy controls may increase an individual's susceptibility to developing epilepsy, with the responsible haploinsufficient gene(s) often being unknown. Large cohort studies have identified such susceptibility CNVs in several chromosomal regions, including well‐known CNVs located at 15q11.2 (BP1‐BP2), 15q13.3 and 16p13.11.<xref ref-type="ref" rid="epi412057-bib-0006">6</xref>, <xref ref-type="ref" rid="epi412057-bib-0007">7</xref>, <xref ref-type="ref" rid="epi412057-bib-0008">8</xref>
</p>
<p>Studies using microarray analysis have most often been performed in research cohorts of children who were selected on the basis of their epilepsy diagnosis, for example, idiopathic generalized epilepsies, focal epilepsies, and/or fever‐associated epilepsies.<xref ref-type="ref" rid="epi412057-bib-0006">6</xref>, <xref ref-type="ref" rid="epi412057-bib-0007">7</xref>, <xref ref-type="ref" rid="epi412057-bib-0008">8</xref> Only a few studies have addressed the yield of microarray analysis in clinical cohorts of all children presenting with any type of seizures in a clinical setting.<xref ref-type="ref" rid="epi412057-bib-0009">9</xref>, <xref ref-type="ref" rid="epi412057-bib-0010">10</xref>, <xref ref-type="ref" rid="epi412057-bib-0011">11</xref> We therefore aimed to evaluate the diagnostic yield of microarray analysis in a hospital‐based cohort of children with epilepsy for whom detailed phenotypic information was available, with the further goal of identifying novel candidate genes or susceptibility loci for epilepsy.</p>
</sec>
<sec id="epi412057-sec-0007">
<title>Material and Methods</title>
<sec id="epi412057-sec-0008">
<title>Study cohort</title>
<p>The study cohort was derived from the childhood seizure database of the University Medical Center Groningen (UMCG), a regional referral center for children with epilepsy. In this database, we retrospectively included all children who presented with their first febrile or afebrile seizure before the age of 18 years between January 2000 and June 2013, and who were seen and/or treated by a child neurologist of the UMCG (n = 1,368). Epilepsy was diagnosed in 91% of these children using the current International League Against Epilepsy (ILAE) practical clinical definition of epilepsy.<xref ref-type="ref" rid="epi412057-bib-0012">12</xref> Of the remaining children (9%), 7% had febrile seizures only and 2% had only one afebrile seizure. The UMCG database contains phenotype information and was independently completed by two researchers (DRMV and PMCC). Phenotypic inconsistencies and epilepsy classification were discussed until agreement was reached using the information in the database as well as in the original medical records (PMCC and OFB). Epilepsy syndromes and seizure types were classified according to the 2006 ILAE classification.<xref ref-type="ref" rid="epi412057-bib-0013">13</xref> Children were included in this study if they underwent microarray analysis in the context of their diagnostic work‐up before June 2014. Formal independent review board evaluation was waived by the Institutional Medical Ethical Committee of the UMCG because of the retrospective and observational character of this study.</p>
</sec>
<sec id="epi412057-sec-0009">
<title>Chromosomal microarray analysis and data interpretation</title>
<p>Microarray analyses were performed using an oligonucleotide array (Agilent 105K or 180K custom HD‐DGH microarray; Agilent Technologies, Santa Clara, CA, U.S.A.) or a single nucleotide polymorphism (SNP) array (Illumina Omni Express 12‐V1.0; Illumina, San Diego, CA, U.S.A.). Cartagenia Bench Lab CNV software was used for storage, analysis and reporting of the structural genomic data (Cartagenia, Leuven, Belgium; part of Agilent Technologies). The chromosomal coordinates of CNVs were reported relative to the Genome Reference Consortium Human Reference genome version 37 (GRCh37/hg19).</p>
<p>CNVs on chromosome 1–22 or X identified by at least three (SNP microarray) or four (oligonucleotide microarray) consecutive probes were evaluated for their pathogenicity (Fig. <xref ref-type="fig" rid="epi412057-fig-0001">1</xref>). CNVs were excluded from further analysis when they did not contain (protein‐coding) genes or had ≥90% overlap with CNVs seen in ≥1% of healthy controls. The prevalence of CNVs in healthy controls was calculated using the International Database of Genomic Variance (n = 14,316, last updated February 2013),<xref ref-type="ref" rid="epi412057-bib-0014">14</xref> the Low Lands Consortium database of oligonucleotides (n = 2,402, last updated December 2012), and SNP microarray results of healthy parents of children who underwent microarray analysis in five Dutch genetic centers (n = 749, last updated October 2014). Remaining CNVs were categorized into two groups: (1) CNVs with &lt;90% overlap with CNVs observed in healthy controls, and (2) CNVs with ≥90% overlap with CNVs observed in &lt;1% of healthy controls (Fig. <xref ref-type="fig" rid="epi412057-fig-0001">1</xref>). CNVs in both groups were marked as potentially clinically relevant if they had overlap with genetic regions previously associated with epilepsy. These regions were identified by performing a literature search using PubMed, complemented with information from the Decipher database and Cartagenia Bench Lab CNV software. The remaining CNVs in both groups were evaluated for novel candidate genes or susceptibility loci for epilepsy. CNVs with &lt;90% overlap with CNVs of healthy controls were of interest if they contained a gene with an expression or function in the brain or a gene associated with an autosomal dominant or X‐linked neuropsychiatric disease, and if they occurred in at least one (for deletions) or two (for duplications) unrelated children in our cohort. In the group of CNVs with ≥90% overlap with CNVs observed in &lt;1% of healthy controls, overlapping regions between CNVs in at least two unrelated children were of interest if these regions contained protein‐coding genes and were 10 times more prevalent in our cohort compared to healthy controls.</p>
<fig fig-type="Figure" id="epi412057-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Flow chart for evaluating copy number variants (<styled-content style="fixed-case">CNV</styled-content>s) in our hospital‐based cohort of children with epilepsy.</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="EPI4-2-244-g001"></graphic>
</fig>
</sec>
<sec id="epi412057-sec-0010">
<title>Statistical analyses</title>
<p>SPSS Statistics Version 22.0 (IBM Corporation, NY, U.S.A.) was used to perform descriptive and comparative statistics. Differences in categorical and ordinal phenotypic data between children were analyzed using Fisher's exact and Mann‐Whitney U tests, respectively.</p>
</sec>
</sec>
<sec id="epi412057-sec-0011">
<title>Results</title>
<sec id="epi412057-sec-0012">
<title>Characteristics of the study cohort</title>
<p>In 226 (17%) children, microarray analysis was performed in the context of their diagnostic work‐up. Their phenotypic characteristics are summarized in Table <xref ref-type="table" rid="epi412057-tbl-0001">1</xref>. All children had a definite diagnosis of epilepsy, except for one who had a single febrile status epilepticus.</p>
<table-wrap id="epi412057-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Characteristics of the study cohort (n = 226)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="2" rowspan="1" valign="top">Characteristics</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Male (%)</td>
<td align="char" colspan="1" rowspan="1">132 (58.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Deceased (%)</td>
<td align="char" colspan="1" rowspan="1">17 (7.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median age at evaluation (range)</td>
<td align="char" colspan="1" rowspan="1">8 years 10 months (1 year 8 months–23 years 3 months)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median age at epilepsy onset (range)</td>
<td align="char" colspan="1" rowspan="1">1 year 1 month (0 days–15 years 11 months)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Seizure types (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">GTCS</td>
<td align="char" colspan="1" rowspan="1">10 (4.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Absences</td>
<td align="char" colspan="1" rowspan="1">5 (2.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Myoclonic seizures</td>
<td align="char" colspan="1" rowspan="1">18 (8.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Epileptic spasms</td>
<td align="char" colspan="1" rowspan="1">36 (15.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Atonic seizures</td>
<td align="char" colspan="1" rowspan="1">12 (5.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Focal seizures</td>
<td align="char" colspan="1" rowspan="1">176 (77.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Secondarily generalized seizures</td>
<td align="char" colspan="1" rowspan="1">123 (54.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Neonatal seizures</td>
<td align="char" colspan="1" rowspan="1">33 (14.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Unclassified</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Status epilepticus (%)</td>
<td align="char" colspan="1" rowspan="1">74 (32.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Epilepsy syndrome (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Benign (familial) neonatal seizures</td>
<td align="char" colspan="1" rowspan="1">7 (3.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Neonatal seizures (not benign)</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Ohtahara syndrome</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Benign familial infantile seizures</td>
<td align="char" colspan="1" rowspan="1">4 (1.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">West syndrome</td>
<td align="char" colspan="1" rowspan="1">36 (15.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Myoclonic epilepsy in infancy</td>
<td align="char" colspan="1" rowspan="1">3 (1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Myoclonic encephalopathy in nonprogressive disorders</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Benign epilepsy with centrotemporal spikes</td>
<td align="char" colspan="1" rowspan="1">5 (2.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Childhood absence epilepsy</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Epilepsy with myoclonic absences</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">CSWS/Landau‐Kleffner syndrome</td>
<td align="char" colspan="1" rowspan="1">9 (4.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Lennox‐Gastaut syndrome</td>
<td align="char" colspan="1" rowspan="1">5 (2.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Juvenile absence epilepsy</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Symptomatic focal epilepsies n.o.s.</td>
<td align="char" colspan="1" rowspan="1">148 (65.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Localization‐related cryptogenic epilepsy</td>
<td align="char" colspan="1" rowspan="1">24 (10.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Other symptomatic generalized epilepsy</td>
<td align="char" colspan="1" rowspan="1">2 (0.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Epilepsy with both generalized and focal seizures</td>
<td align="char" colspan="1" rowspan="1">3 (1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Febrile seizures plus</td>
<td align="char" colspan="1" rowspan="1">5 (2.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Febrile infection related epilepsy syndrome</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">One febrile status epilepticus</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">One seizure likely to reoccur</td>
<td align="char" colspan="1" rowspan="1">2 (0.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Epilepsies of unknown cause</td>
<td align="char" colspan="1" rowspan="1">1 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Seizure free<xref ref-type="fn" rid="epi412057-note-0004">a</xref> (%)</td>
<td align="char" colspan="1" rowspan="1">89/192 (46.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Family history of epilepsy<xref ref-type="fn" rid="epi412057-note-0005">b</xref> (%)</td>
<td align="char" colspan="1" rowspan="1">68/200 (34.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Developmental problems in speech, language, motor skills, and/or cognition (%)</td>
<td align="char" colspan="1" rowspan="1">195 (86.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Behavioral/psychiatric problems (%)</td>
<td align="char" colspan="1" rowspan="1">104 (46.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Microcephaly (≤−2 SD) (%)</td>
<td align="char" colspan="1" rowspan="1">40 (17.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Macrocephaly (≥2 SD) %)</td>
<td align="char" colspan="1" rowspan="1">13 (5.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Short stature (≤−2 SD) (%)</td>
<td align="char" colspan="1" rowspan="1">39 (17.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tall stature (≥2 SD) %)</td>
<td align="char" colspan="1" rowspan="1">13 (5.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Facial dysmorphisms (%)</td>
<td align="char" colspan="1" rowspan="1">109 (48.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Congenital anomalies (%)</td>
<td align="char" colspan="1" rowspan="1">72 (31.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRI abnormalities (%)</td>
<td align="char" colspan="1" rowspan="1">118/218 (54.1)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412057-note-0002">
<p>CSWS, continuous spike during slow‐wave sleep; GTCS, generalized seizures with tonic and/or clonic manifestations; MRI, magnetic resonance imaging; n.o.s., not otherwise specified; SD, standard deviation.</p>
</fn>
<fn id="epi412057-note-0003">
<p>Epilepsy syndromes and seizure types were classified according to the International League Against Epilepsy (ILAE) classification of 2006.<xref ref-type="ref" rid="epi412057-bib-0013">13</xref>
</p>
</fn>
<fn id="epi412057-note-0004">
<label>a</label>
<p>Seizure freedom was defined as present if a patient had no clinical seizures for at least 1 year at the time of evaluation.</p>
</fn>
<fn id="epi412057-note-0005">
<label>b</label>
<p>Family history of epilepsy was positive if a first‐ or second‐degree relative has epilepsy.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Children with epilepsy who underwent microarray analysis had significantly more often developmental problems (82% vs. 25%, p &lt; 0.001), facial dysmorphisms (49% vs. 8%, p &lt; 0.001), or behavioral problems (41% vs. 13%, p &lt; 0.001) than children in our database who did not undergo microarray analysis. To reduce bias, our comparisons were limited to children with epilepsy onset after December 31, 2005, when microarray analysis was introduced in our center (n = 158 for children with array; n = 271 for children without array or another identified genetic cause). The presence of a positive family history for epilepsy, known in 141/158 children who did and in 206/271 children who did not undergo microarray, did not differ significantly (33% vs. 30%, p = 0.56) between the two groups.</p>
</sec>
<sec id="epi412057-sec-0013">
<title>Diagnostic yield of microarray analysis</title>
<p>Microarray analysis revealed 1,982 CNVs in 226 children (Fig. <xref ref-type="fig" rid="epi412057-fig-0001">1</xref>). After excluding CNVs that contained no (protein‐coding) genes and/or were identified as most likely benign polymorphisms (≥90% overlap in ≥1% of controls), 408 CNVs in 181 children remained to be evaluated for their pathogenicity. These 408 CNVs included 233 (57.1%) duplications with a median size of 198.8 kb (range 17.9 kb–21.0 Mb) and 175 (42.9%) deletions with a median size of 168.4 kb (range 22.4 kb–21.0 Mb). Inheritance could be analyzed for 102 (25.0%) CNVs, with 23 (22.5%) occurring de novo and 79 (77.5%) being inherited.</p>
<p>Known clinically relevant CNVs for epilepsy were identified in 24 of the 226 (11%) children with epilepsy (Fig. <xref ref-type="fig" rid="epi412057-fig-0001">1</xref>, Tables <xref ref-type="table" rid="epi412057-tbl-0002">2</xref> and <xref ref-type="table" rid="epi412057-tbl-0003">3</xref>). Their epilepsy was most often classified as symptomatic focal epilepsy not otherwise specified (71%) or West syndrome (21%). All children had developmental problems (100%), and many had behavioral problems (54%) and facial dysmorphisms (46%). Overall, no significant differences were found between children with and without clinically relevant CNVs for epilepsy syndrome diagnosis or the presence of other phenotypic characteristics (data not shown).</p>
<table-wrap id="epi412057-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Clinically relevant CNVs with &lt;90% overlap with CNVs observed in healthy controls (n = 14)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patient</th>
<th align="char" colspan="1" rowspan="1" valign="top">Sex, age (years)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Microarray results</th>
<th align="char" colspan="1" rowspan="1" valign="top">CNV size in kilobases</th>
<th align="char" colspan="1" rowspan="1" valign="top">Inheritance (parental phenotype)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Relevant genes</th>
<th align="char" colspan="1" rowspan="1" valign="top">Epilepsy syndrome</th>
<th align="char" colspan="1" rowspan="1" valign="top">Age at epilepsy onset</th>
<th align="char" colspan="1" rowspan="1" valign="top">Age at last seizure</th>
<th align="char" colspan="1" rowspan="1" valign="top">Developmental problems</th>
<th align="char" colspan="1" rowspan="1" valign="top">Behavioral problems</th>
<th align="char" colspan="1" rowspan="1" valign="top">Microcephaly (≤−2SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Macrocephaly (≥2 SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Short stature (≤−2SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Tall stature (≥2 SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Facial dysmorphisms</th>
<th align="char" colspan="1" rowspan="1" valign="top">Congenital anomalies</th>
<th align="char" colspan="1" rowspan="1" valign="top">MRI abnormalities</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1,040</td>
<td align="char" colspan="1" rowspan="1">F, 3.5†</td>
<td align="char" colspan="1" rowspan="1">arr 1p34.1p33(46,089,475–46,738,333)×3<xref ref-type="fn" rid="epi412057-note-0008">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">649</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">1 years</td>
<td align="char" colspan="1" rowspan="1">3.5 years†</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,032</td>
<td align="char" colspan="1" rowspan="1">M, 8</td>
<td align="char" colspan="1" rowspan="1">arr 1p36.33p36.31(746,419–5,696,745)×1<xref ref-type="fn" rid="epi412057-note-0009">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">4,950</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
<italic>GABRD KLHL17</italic>
</td>
<td align="char" colspan="1" rowspan="1">WS</td>
<td align="char" colspan="1" rowspan="1">3 months</td>
<td align="char" colspan="1" rowspan="1">21 months</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">590</td>
<td align="char" colspan="1" rowspan="1">F, 10</td>
<td align="char" colspan="1" rowspan="1">arr 1p36.33p36.23(564,224–8,104,812)×1<xref ref-type="fn" rid="epi412057-note-0009">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">7,541</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">
GABRD KLHL17<break></break>
KCNAB2
</td>
<td align="char" colspan="1" rowspan="1">WS, focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">1 month</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">183</td>
<td align="char" colspan="1" rowspan="1">M, 11</td>
<td align="char" colspan="1" rowspan="1">arr 2q23.1(148,775,316–149,002,634)×1<xref ref-type="fn" rid="epi412057-note-0010">c</xref>
</td>
<td align="char" colspan="1" rowspan="1">227</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
<italic>MBD5</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">2 years 3 months</td>
<td align="char" colspan="1" rowspan="1">2 years 3 months</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,105</td>
<td align="char" colspan="1" rowspan="1">F, 2</td>
<td align="char" colspan="1" rowspan="1">arr 2q22.3q23.3(146,506,579–151,355,790)×1<xref ref-type="fn" rid="epi412057-note-0010">c</xref>
</td>
<td align="char" colspan="1" rowspan="1">4,849</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">
<italic>MBD5</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">2 months</td>
<td align="char" colspan="1" rowspan="1">9 months</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">575</td>
<td align="char" colspan="1" rowspan="1">F, 6</td>
<td align="char" colspan="1" rowspan="1">arr 8q22.3(101,795,020–104,406,406)×1</td>
<td align="char" colspan="1" rowspan="1">2,611</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">Undet.<xref ref-type="fn" rid="epi412057-note-0019">l</xref>
</td>
<td align="char" colspan="1" rowspan="1">1 year</td>
<td align="char" colspan="1" rowspan="1">4.5 years</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,037</td>
<td align="char" colspan="1" rowspan="1">M, 4†</td>
<td align="char" colspan="1" rowspan="1">
arr 13q31.3q34(94,017,655–115,105,959)×3,<break></break>
18q21.32q23 (56,921,091–78,010,172)×1<xref ref-type="fn" rid="epi412057-note-0011">d</xref>
</td>
<td align="char" colspan="1" rowspan="1">21,088</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">WS, focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">2 years</td>
<td align="char" colspan="1" rowspan="1">4 years†</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,079</td>
<td align="char" colspan="1" rowspan="1">M, 4</td>
<td align="char" colspan="1" rowspan="1">arr 15q11.2q13.1(22,285,091–28,940,239)×1<xref ref-type="fn" rid="epi412057-note-0012">e</xref>
</td>
<td align="char" colspan="1" rowspan="1">6,655</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
GABRB3<break></break>
UBE3A
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">7 months</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">356</td>
<td align="char" colspan="1" rowspan="1">M, 16</td>
<td align="char" colspan="1" rowspan="1">arr 15q11.2q13.1(22,668,852–29,045,487)×3<xref ref-type="fn" rid="epi412057-note-0013">f</xref>
</td>
<td align="char" colspan="1" rowspan="1">6,377</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
GABRB3<break></break>
UBE3A
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">7 years</td>
<td align="char" colspan="1" rowspan="1">14 years</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,062</td>
<td align="char" colspan="1" rowspan="1">M, 5</td>
<td align="char" colspan="1" rowspan="1">arr 15q11.2q13.1(22,668,852–29,060,634)×3<xref ref-type="fn" rid="epi412057-note-0013">f</xref>
</td>
<td align="char" colspan="1" rowspan="1">6,392</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
GABRB3<break></break>
UBE3A
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">8 months</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">319</td>
<td align="char" colspan="1" rowspan="1">F, 13</td>
<td align="char" colspan="1" rowspan="1">arr 16p11.2(29,620,489–30,199,507)×1<xref ref-type="fn" rid="epi412057-note-0014">g</xref>
</td>
<td align="char" colspan="1" rowspan="1">579</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
<italic>PRRT2</italic>
</td>
<td align="char" colspan="1" rowspan="1">BFIS</td>
<td align="char" colspan="1" rowspan="1">4 months</td>
<td align="char" colspan="1" rowspan="1">4 years</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,081</td>
<td align="char" colspan="1" rowspan="1">M, 4</td>
<td align="char" colspan="1" rowspan="1">arr 17p13.3(2,355,353–3,322,779)×1<xref ref-type="fn" rid="epi412057-note-0015">h</xref>
</td>
<td align="char" colspan="1" rowspan="1">967</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
<italic>PAFAH1B1</italic>
</td>
<td align="char" colspan="1" rowspan="1">WS, focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">3 months</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">201</td>
<td align="char" colspan="1" rowspan="1">M, 16</td>
<td align="char" colspan="1" rowspan="1">arr 22q13.3(51,125,351–51,219,150)×1<xref ref-type="fn" rid="epi412057-note-0016">i</xref>
</td>
<td align="char" colspan="1" rowspan="1">94</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">
<italic>SHANK3</italic>
</td>
<td align="char" colspan="1" rowspan="1">Undet.<xref ref-type="fn" rid="epi412057-note-0019">l</xref>
</td>
<td align="char" colspan="1" rowspan="1">9 years</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">831</td>
<td align="char" colspan="1" rowspan="1">F, 11</td>
<td align="char" colspan="1" rowspan="1">arr Xq22.1(99,582,921–99,671,028)×1<xref ref-type="fn" rid="epi412057-note-0017">j</xref>
</td>
<td align="char" colspan="1" rowspan="1">88</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
<italic>PCDH19</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0018">k</xref>
</td>
<td align="char" colspan="1" rowspan="1">2 years</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412057-note-0006">
<p>BFIS, benign familial infantile seizures; CNVs, copy number variants; F, female; M, male; MRI, magnetic resonance imaging; NA, not applicable (not seizure‐free); SD, standard deviation; U, unknown; WS, West syndrome; †, deceased; +, phenotype is present in the child; −, phenotype is absent in the child.</p>
</fn>
<fn id="epi412057-note-0007">
<p>The chromosomal coordinates are reported relative to the Genome Reference Consortium Human Reference genome version 37 (GRCh37/hg19).</p>
</fn>
<fn id="epi412057-note-0008">
<label>a</label>
<p>Previously published by some of us.<xref ref-type="ref" rid="epi412057-bib-0015">15</xref>
</p>
</fn>
<fn id="epi412057-note-0009">
<label>b</label>
<p>Chromosome 1p36 deletion syndrome (MIM 607872).</p>
</fn>
<fn id="epi412057-note-0010">
<label>c</label>
<p>Chromosome 2q23.1 deletion syndrome (MIM 156200).</p>
</fn>
<fn id="epi412057-note-0011">
<label>d</label>
<p>Chromosome 18q deletion syndrome (MIM 601808).</p>
</fn>
<fn id="epi412057-note-0012">
<label>e</label>
<p>Angelman syndrome (MIM 105830).</p>
</fn>
<fn id="epi412057-note-0013">
<label>f</label>
<p>Chromosome 15q11–15q13 duplication syndrome (MIM 608636).</p>
</fn>
<fn id="epi412057-note-0014">
<label>g</label>
<p>Chromosome 16p11.2 deletion syndrome (MIM 611913).</p>
</fn>
<fn id="epi412057-note-0015">
<label>h</label>
<p>Lissencephaly type 1 (MIM 607432).</p>
</fn>
<fn id="epi412057-note-0016">
<label>i</label>
<p>Phelan‐McDermid syndrome (MIM 606232).</p>
</fn>
<fn id="epi412057-note-0017">
<label>j</label>
<p>Juberg‐Hellman syndrome (MIM 300088; epilepsy, female restricted with mental retardation [EFMR]).</p>
</fn>
<fn id="epi412057-note-0018">
<label>k</label>
<p>Symptomatic focal epilepsy not otherwise specified.</p>
</fn>
<fn id="epi412057-note-0019">
<label>l</label>
<p>Other undetermined epilepsy with both generalized and focal seizures.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<table-wrap id="epi412057-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Clinically relevant CNVs with ≥90% overlap with CNVs observed in &lt;1% of healthy controls (n = 10)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patient</th>
<th align="char" colspan="1" rowspan="1" valign="top">Sex, age (years)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Microarray results</th>
<th align="char" colspan="1" rowspan="1" valign="top">CNV size in kilobases</th>
<th align="char" colspan="1" rowspan="1" valign="top">Inheritance (parental phenotype)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Relevant genes</th>
<th align="char" colspan="1" rowspan="1" valign="top">Epilepsy syndrome</th>
<th align="char" colspan="1" rowspan="1" valign="top">Age at epilepsy onset</th>
<th align="char" colspan="1" rowspan="1" valign="top">Age at last seizure</th>
<th align="char" colspan="1" rowspan="1" valign="top">Developmental problems</th>
<th align="char" colspan="1" rowspan="1" valign="top">Behavioral problems</th>
<th align="char" colspan="1" rowspan="1" valign="top">Microcephaly (≤−2SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Macrocephaly (≥2 SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Short stature (≤−2SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Tall stature (≥2 SD)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Facial dysmorphisms</th>
<th align="char" colspan="1" rowspan="1" valign="top">Congenital anomalies</th>
<th align="char" colspan="1" rowspan="1" valign="top">MRI abnormalities</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">822</td>
<td align="char" colspan="1" rowspan="1">F, 6</td>
<td align="char" colspan="1" rowspan="1">arr 1q21.1(145,395,197–146,089,261)×3</td>
<td align="char" colspan="1" rowspan="1">694</td>
<td align="char" colspan="1" rowspan="1">Pat (none)</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">WS, focal<xref ref-type="fn" rid="epi412057-note-0022">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">6 months</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">337</td>
<td align="char" colspan="1" rowspan="1">F, 13</td>
<td align="char" colspan="1" rowspan="1">arr 2p16.3(50,968,252–51,579,862)×1<xref ref-type="fn" rid="epi412057-note-0023">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">612</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
<italic>NRXN1</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0022">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">3.5 years</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,000</td>
<td align="char" colspan="1" rowspan="1">M, 16</td>
<td align="char" colspan="1" rowspan="1">arr 15q11.2(20,279,343–23,300,438)×1</td>
<td align="char" colspan="1" rowspan="1">3,021</td>
<td align="char" colspan="1" rowspan="1">Pat (none)</td>
<td align="char" colspan="1" rowspan="1">
<italic>CYFIP1, NIPA1, NIPA2</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0022">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">11 years</td>
<td align="char" colspan="1" rowspan="1">13 years</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">225</td>
<td align="char" colspan="1" rowspan="1">M, 11</td>
<td align="char" colspan="1" rowspan="1">arr 15q11.2(22,698,322–23,217,655)×1<xref ref-type="fn" rid="epi412057-note-0024">c</xref>
</td>
<td align="char" colspan="1" rowspan="1">519</td>
<td align="char" colspan="1" rowspan="1">Pat (none)</td>
<td align="char" colspan="1" rowspan="1">
<italic>CYFIP1, NIPA1, NIPA2</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0022">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">6 years</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,099</td>
<td align="char" colspan="1" rowspan="1">F, 8</td>
<td align="char" colspan="1" rowspan="1">arr 15q13.3(30,921,717–32,515,121)×1</td>
<td align="char" colspan="1" rowspan="1">1,593</td>
<td align="char" colspan="1" rowspan="1">De novo</td>
<td align="char" colspan="1" rowspan="1">
<italic>CHRNA7</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0022">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">4 years</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">372</td>
<td align="char" colspan="1" rowspan="1">M, 9</td>
<td align="char" colspan="1" rowspan="1">arr 15q13.3(30,833,546–32,861,767)×3</td>
<td align="char" colspan="1" rowspan="1">2,028</td>
<td align="char" colspan="1" rowspan="1">Mat (none)</td>
<td align="char" colspan="1" rowspan="1">
<italic>CHRNA7</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0022">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">11 months</td>
<td align="char" colspan="1" rowspan="1">6 years</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">761</td>
<td align="char" colspan="1" rowspan="1">F, 13</td>
<td align="char" colspan="1" rowspan="1">arr 16p11.2(29,620,488–30,198,752)×3</td>
<td align="char" colspan="1" rowspan="1">578</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">
<italic>PRRT2</italic>
</td>
<td align="char" colspan="1" rowspan="1">CSWS</td>
<td align="char" colspan="1" rowspan="1">4 years</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">730</td>
<td align="char" colspan="1" rowspan="1">M, 12</td>
<td align="char" colspan="1" rowspan="1">arr 16p11.2(29,592,582–30,198,752)×3</td>
<td align="char" colspan="1" rowspan="1">606</td>
<td align="char" colspan="1" rowspan="1">Unknown</td>
<td align="char" colspan="1" rowspan="1">
<italic>PRRT2</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0022">a</xref>
</td>
<td align="char" colspan="1" rowspan="1">1 months</td>
<td align="char" colspan="1" rowspan="1">8 years</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">270</td>
<td align="char" colspan="1" rowspan="1">M, 14</td>
<td align="char" colspan="1" rowspan="1">arr 16p13.11(14,944,359–16,525,488)×1</td>
<td align="char" colspan="1" rowspan="1">1,581</td>
<td align="char" colspan="1" rowspan="1">Pat (FS)</td>
<td align="char" colspan="1" rowspan="1">
<italic>NDE1</italic>
</td>
<td align="char" colspan="1" rowspan="1">One FS</td>
<td align="char" colspan="1" rowspan="1">2.5 years</td>
<td align="char" colspan="1" rowspan="1">2.5 years</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">1,045</td>
<td align="char" colspan="1" rowspan="1">M, 6</td>
<td align="char" colspan="1" rowspan="1">arr 16p13.11(14,944,360–16,561,292)×1</td>
<td align="char" colspan="1" rowspan="1">1,617</td>
<td align="char" colspan="1" rowspan="1">Mat (FS)</td>
<td align="char" colspan="1" rowspan="1">
<italic>NDE1</italic>
</td>
<td align="char" colspan="1" rowspan="1">MAE</td>
<td align="char" colspan="1" rowspan="1">1.5 years</td>
<td align="char" colspan="1" rowspan="1">NA</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">+</td>
<td align="char" colspan="1" rowspan="1">−</td>
<td align="char" colspan="1" rowspan="1">−</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412057-note-0020">
<p>BECTS, benign epilepsy with centrotemporal spikes; CAE, childhood absence epilepsy; CNVs, copy number variants; CSWS, continuous spike waves during slow‐wave sleep syndrome; F, female; FS, febrile seizures; JME, juvenile myoclonic epilepsy; M, male; mat., maternal; MAE, epilepsy with myoclonic absences; NA, not applicable (not seizure‐free); SD, standard deviation; U, unknown; pat, paternal; WS, West syndrome; +, phenotype is present in the child; −, phenotype is absent in the child.</p>
</fn>
<fn id="epi412057-note-0021">
<p>The chromosomal coordinates are reported relative to the Genome Reference Consortium Human Reference genome version 37 (GRCh37/hg19).</p>
</fn>
<fn id="epi412057-note-0022">
<label>a</label>
<p>Symptomatic focal epilepsy not otherwise specified.</p>
</fn>
<fn id="epi412057-note-0023">
<label>b</label>
<p>This patient also carries a chromosome 14q31.1 deletion including the <italic>NRXN3</italic> gene.</p>
</fn>
<fn id="epi412057-note-0024">
<label>c</label>
<p>This patient also carries a likely pathogenic sequence variant in the <italic>SLC2A1</italic> gene associated with GLUT‐1 deficiency.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In 14 (7%) children, 15 known clinically relevant CNVs were found that do not occur in healthy controls (Table <xref ref-type="table" rid="epi412057-tbl-0002">2</xref>). Ten of these CNVs occurred de novo. For the remaining CNVs, inheritance was unknown. The phenotypes of these 14 children were compatible with previously reported phenotypes associated with these CNVs and included the well‐established diagnoses: chromosome 1p36 deletion syndrome (MIM 607872), chromosome 2q23.1 deletion syndrome (MIM 156200), chromosome 18q deletion syndrome (MIM 601808), Angelman syndrome (MIM 105830), chromosome 15q11q13 duplication syndrome (MIM 608636), chromosome 16p11.2 deletion syndrome (MIM 611913), lissencephaly type 1 (MIM 607432), Phelan‐McDermid syndrome (MIM 606232), and Juberg‐Hellman syndrome (MIM 300088; epilepsy, female restricted, with mental retardation) (Table <xref ref-type="table" rid="epi412057-tbl-0002">2</xref>). One patient had a 2.6 Mb 8q22 deletion; comparable deletions have been published in six other cases.<xref ref-type="ref" rid="epi412057-bib-0016">16</xref>, <xref ref-type="ref" rid="epi412057-bib-0017">17</xref>
</p>
<p>In 10 (4%) children, known clinically relevant CNVs were found that also occur in healthy controls, albeit in &lt;1% (Table <xref ref-type="table" rid="epi412057-tbl-0003">3</xref>). Six of these CNVs (60%) were inherited from an affected (n = 2) or non‐affected (n = 4) parent, and two (20%) CNVs occurred de novo (the deletions including <italic>NRXN1</italic> and <italic>CHRNA7</italic>). In three (30%) children, another cause for epilepsy—one not associated with the CNVs—was identified. These were developmental anomalies of cerebral structure (Patient 822), a GLUT1‐deficiency (Patient 225), and polymicrogyria (Patient 761) (Table <xref ref-type="table" rid="epi412057-tbl-0003">3</xref>).</p>
</sec>
<sec id="epi412057-sec-0014">
<title>Novel CNVs of interest for epilepsy</title>
<p>In 5 (2%) children, we identified novel CNVs of interest that were not found in healthy controls (Table <xref ref-type="table" rid="epi412057-tbl-0004">4</xref>). These CNVs comprised four potential candidate genes for epilepsy: <italic>MYT1L, UNC5D, SCN4B</italic> and <italic>NRXN3</italic> (see Table <xref ref-type="supplementary-material" rid="epi412057-sup-0002">S1</xref> for more information on these genes).</p>
<table-wrap id="epi412057-tbl-0004" orientation="portrait" position="float" xml:lang="en">
<label>Table 4</label>
<caption>
<p>Novel CNVs in our cohort of children with epilepsy (n = 5)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patient (sex, age in years)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Microarray results, inheritance</th>
<th align="char" colspan="1" rowspan="1" valign="top">CNV size in kilobases</th>
<th align="char" colspan="1" rowspan="1" valign="top">Relevant genes</th>
<th align="char" colspan="1" rowspan="1" valign="top">Seizure types (estimated number of seizures)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Age at active epilepsy</th>
<th align="char" colspan="1" rowspan="1" valign="top">Epileptiform activity on EEG (localization)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Anti‐epileptic drugs (effectiveness)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Epilepsy syndrome</th>
<th align="char" colspan="1" rowspan="1" valign="top">Additional features</th>
<th align="char" colspan="1" rowspan="1" valign="top">MRI abnormalities</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">981 (M, 16)</td>
<td align="char" colspan="1" rowspan="1">arr 2p25.3 (1,711,399–2,078,557)×1, de novo</td>
<td align="char" colspan="1" rowspan="1">376</td>
<td align="char" colspan="1" rowspan="1">
<italic>MYT1L</italic>
</td>
<td align="char" colspan="1" rowspan="1">Frontal absences (3/day), sec. gen. sz. (4)</td>
<td align="char" colspan="1" rowspan="1">3–12 years</td>
<td align="char" colspan="1" rowspan="1">Gen. 3‐Hz SWC, focal spikes and SWC (fronto‐temp., L &gt; R)</td>
<td align="char" colspan="1" rowspan="1">
ETX (−)<break></break>
LEV (+)
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0028">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">Developmental problems, autism, pubertas praecox, upslanting palpebral fissures</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">626 (F, 9)</td>
<td align="char" colspan="1" rowspan="1">arr 8p12 (35,120,621–35,358,315)×1, paternal father has migraine)</td>
<td align="char" colspan="1" rowspan="1">238</td>
<td align="char" colspan="1" rowspan="1">
<italic>UNC5D</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal SE (1), focal sz. (10)</td>
<td align="char" colspan="1" rowspan="1">3 years–ongoing</td>
<td align="char" colspan="1" rowspan="1">Gen. SWC (max. bifront.), focal sharp waves and SWC (L temp.)</td>
<td align="char" colspan="1" rowspan="1">
VPA (side effects)<break></break>
CBZ (+)
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0028">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">Developmental and behavioral problems</td>
<td align="char" colspan="1" rowspan="1">MTS and possible left cortical dysplasia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">31 (M, 23)</td>
<td align="char" colspan="1" rowspan="1">arr 11q23.3 (117,951,629–118,022,700)×1, unknown</td>
<td align="char" colspan="1" rowspan="1">71</td>
<td align="char" colspan="1" rowspan="1">
<italic>SCN4B</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal sz. (unknown), sec. gen. sz. (1)</td>
<td align="char" colspan="1" rowspan="1">14 years–unknown</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" colspan="1" rowspan="1">
VPA (side effects)<break></break>
TPM (+)<break></break>
LTG (unknown)
</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0028">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">Perinatal asphyxia, developmental and behavioral problems, dyskinesia</td>
<td align="char" colspan="1" rowspan="1">Diffuse white matter abnormality</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">337 (F, 13)</td>
<td align="char" colspan="1" rowspan="1">arr 14q31.1 (79,335,493–79,654,245)×1<xref ref-type="fn" rid="epi412057-note-0027">a</xref>, de novo</td>
<td align="char" colspan="1" rowspan="1">319</td>
<td align="char" colspan="1" rowspan="1">
<italic>NRXN3</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal sz. (unknown)</td>
<td align="char" colspan="1" rowspan="1">3.5 years–ongoing</td>
<td align="char" colspan="1" rowspan="1">Focal sharp waves (occ.)</td>
<td align="char" colspan="1" rowspan="1">None</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0028">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">Developmental problems, hearing loss, microcephaly, thick eyebrows, deeply set eyes, entropion, thin lips, high nasal bridge, abnormal position of ears, short stature, pectus excavatum</td>
<td align="char" colspan="1" rowspan="1">Megacisterna magna</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">969 (F, 8)</td>
<td align="char" colspan="1" rowspan="1">arr 14q24.3q31.1 (76,621,116–79,828,269)×1, de novo</td>
<td align="char" colspan="1" rowspan="1">3,207</td>
<td align="char" colspan="1" rowspan="1">
<italic>NRXN3</italic>
</td>
<td align="char" colspan="1" rowspan="1">Focal SE (1), focal sz. (2–4/month)</td>
<td align="char" colspan="1" rowspan="1">2–4 years</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
<td align="char" colspan="1" rowspan="1">VPA (+)</td>
<td align="char" colspan="1" rowspan="1">Focal<xref ref-type="fn" rid="epi412057-note-0028">b</xref>
</td>
<td align="char" colspan="1" rowspan="1">PDD‐NOS, epicanthal fold, fifth finger clinodactyly</td>
<td align="char" colspan="1" rowspan="1">Normal</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412057-note-0025">
<p>bifront., bifrontal; CBZ, carbamazepine; CNVs, copy number variants; EEG, electroencephalogram; ETX, ethosuximide; F, female; fronto‐temp., fronto‐temporal; gen., generalized; Hz, Hertz; L, left; LEV, levetiracetam; LTG, lamotrigine; M, male; max., maximum; MRI, magnetic resonance imaging; MTS, mesiotemporal sclerosis; occ., occipital; Pat, paternal; PDD‐NOS, pervasive developmental disorder not otherwise specific; R, right; SE, status epilepticus; sec. gen., secondarily generalized; SWC, spike‐wave complexes; sz., seizures; temp., temporal; TPM, topiramate; VPA, valproic acid; +, &gt;50% seizure frequency reduction; −, &lt;50% seizure frequency reduction.</p>
</fn>
<fn id="epi412057-note-0026">
<p>The chromosomal coordinates are reported relative to the Genome Reference Consortium Human Reference genome version 37 (GRCh37/hg19).</p>
</fn>
<fn id="epi412057-note-0027">
<label>a</label>
<p>This patient also carries a chromosome 2p16.3 deletion including the <italic>NRXN1</italic> gene.</p>
</fn>
<fn id="epi412057-note-0028">
<label>b</label>
<p>Symptomatic focal epilepsy not otherwise specified.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In 16 (7%) children, eight different overlapping deletions (n = 4) and duplications (n = 4) occurred at a 10 times higher frequency in our cohort than in healthy controls (Table <xref ref-type="supplementary-material" rid="epi412057-sup-0003">S2</xref>). However, another cause for epilepsy was identified in 7 (44%) of these children, with CNVs involving six of the eight regions. The two remaining regions did not contain genes that seem of particular interest for epilepsy (Table <xref ref-type="supplementary-material" rid="epi412057-sup-0003">S2</xref>).</p>
</sec>
</sec>
<sec id="epi412057-sec-0015">
<title>Discussion</title>
<p>Our study was performed in a university hospital–based cohort of children with epilepsy, who were selected on the basis of their doctors' preference to undergo microarray analysis as part of their diagnostic work‐up. We found that microarray analysis yielded known clinically relevant CNVs for epilepsy in 11% of the children. We further identified five novel CNVs of interest for epilepsy in 2% of the children.</p>
<sec id="epi412057-sec-0016">
<title>Diagnostic yield of microarray analysis</title>
<p>The 11% yield of microarray analysis in our cohort is comparable with the 9% yield found in another clinical cohort of American individuals with epilepsy.<xref ref-type="ref" rid="epi412057-bib-0009">9</xref> Higher yields of 36–40% have been reported in smaller cohorts of Saudi individuals with epilepsy.<xref ref-type="ref" rid="epi412057-bib-0010">10</xref>, <xref ref-type="ref" rid="epi412057-bib-0011">11</xref> Differences in yield between studies is probably due to the selection of children for microarray analysis, which is often based on the presence of additional features other than epilepsy. For example, a higher yield of microarray analysis is found in individuals with epilepsy when the epilepsy is accompanied by global developmental delay or cognitive dysfunction.<xref ref-type="ref" rid="epi412057-bib-0018">18</xref> In our database, children who underwent microarray analysis more often had developmental problems, facial dysmorphisms and behavioral problems when compared to those who did not underwent microarray analysis. Thus, the presence of such comorbidities prompted the treating physicians to request a microarray analysis. Probably because of this selection, we found no differences in epilepsy syndrome diagnosis or the presence of other phenotypic characteristics between children with and without clinically relevant CNVs.</p>
<p>We found a 2.6 Mb 8q22 deletion in one child. She (Patient 575) is the seventh individual reported with such a deletion so far and shares the combination of absence seizures and focal seizures with two of the previously reported children.<xref ref-type="ref" rid="epi412057-bib-0016">16</xref>, <xref ref-type="ref" rid="epi412057-bib-0017">17</xref> An eighth individual, listed in the DECIPHER database (Case 2846), also has an 8q22 deletion and absence seizures. Thus, both focal and generalized (especially absences) seizures may occur in patients with 8q22 deletions. The smallest region of overlap harbors two candidate genes for epilepsy, <italic>NCALD</italic> (MIM 606722) and <italic>RRM2B</italic> (MIM 604712), which both have a function in the brain (Figure <xref ref-type="supplementary-material" rid="epi412057-sup-0001">S1</xref>).<xref ref-type="ref" rid="epi412057-bib-0017">17</xref>
</p>
<p>A large proportion of identified CNVs are also observed in &lt;1% of the healthy controls. Among these CNVs were chromosome 15q11.2 and 15q13.3 deletions in three children with symptomatic focal epilepsy, while similar deletions are known to predispose to idiopathic generalized epilepsies (Table <xref ref-type="table" rid="epi412057-tbl-0003">3</xref>).<xref ref-type="ref" rid="epi412057-bib-0006">6</xref>, <xref ref-type="ref" rid="epi412057-bib-0007">7</xref>, <xref ref-type="ref" rid="epi412057-bib-0008">8</xref>, <xref ref-type="ref" rid="epi412057-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412057-bib-0020">20</xref> We also found a chromosome 15q13.3 duplication in a child with focal seizures. An association between 15q13.3 duplications and epilepsy has only been reported in a few cases so far.<xref ref-type="ref" rid="epi412057-bib-0009">9</xref>, <xref ref-type="ref" rid="epi412057-bib-0021">21</xref> The observations in our cohort suggest that chromosome 15q11.2 and 15q13.3 deletions and duplications might predispose to both generalized and focal epilepsies. Although these CNVs are regarded as susceptibility CNVs for epilepsy, one should always consider that other causes of epilepsy may also be present, as seen in 30% of the children with susceptibility CNVs in our cohort (Table <xref ref-type="table" rid="epi412057-tbl-0003">3</xref>).</p>
</sec>
<sec id="epi412057-sec-0017">
<title>Novel CNVs of interest for epilepsy</title>
<p>In five children, we identified novel CNVs comprising four candidate genes for epilepsy (<italic>MYT1L, UNC5D, SCN4B</italic> and <italic>NRXN3</italic>) with either expression or function in the brain or a previous association with neurodevelopmental disorders (Table <xref ref-type="supplementary-material" rid="epi412057-sup-0002">S1</xref>).</p>
<p>We found a 376‐kb deletion involving the <italic>MYT1L</italic> gene (MIM 613084) in a child with focal epilepsy and intellectual disability. <italic>MYT1L</italic> codes for a transcription factor that has an important role in the differentiation of cells to functional neurons.<xref ref-type="ref" rid="epi412057-bib-0022">22</xref> It has been identified as a candidate gene for intellectual disability in patients with 2p25.3 deletions,<xref ref-type="ref" rid="epi412057-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412057-bib-0024">24</xref> and seizures have been reported in 8/21 patients with such a deletion.<xref ref-type="ref" rid="epi412057-bib-0007">7</xref>, <xref ref-type="ref" rid="epi412057-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412057-bib-0025">25</xref> The DECIPHER database includes another individual (Case 259324) with absence seizures, intellectual disability, autism and a large chromosome 2p25 deletion including <italic>MYT1L</italic>. Thus, based on our and previous observations, <italic>MYTL1</italic> deletions are not only associated with intellectual disability but also with epilepsy.</p>
<p>We found a deletion of <italic>UNC5D</italic> in a child with focal epilepsy, mesiotemporal sclerosis and developmental and behavioral problems, as well as in his father who had migraine. <italic>UNC5D</italic> (MIM 616466) on chromosome 8p12 has been shown to be involved in cortical development and p53‐dependent apoptosis in neuroblastoma cells.<xref ref-type="ref" rid="epi412057-bib-0026">26</xref>, <xref ref-type="ref" rid="epi412057-bib-0027">27</xref>
<italic>UNC5D</italic> was considered as a candidate gene for neurodevelopmental phenotypes in a family with a t(6;8) balanced translocation that disrupted this gene in two affected siblings with developmental delay (one with schizencephaly) and their asymptomatic mother.<xref ref-type="ref" rid="epi412057-bib-0028">28</xref> Further confirmation that deletion of the <italic>UNC5D</italic> gene may cause or predispose to epilepsy and developmental problems is, however, needed.</p>
<p>In one child from our cohort with focal epilepsy and developmental problems, we found a deletion of the sodium channel voltage‐gated type IV beta subunit gene, <italic>SCN4B</italic> (MIM 608256). <italic>SCN4B</italic> is expressed in rat brain and spinal cords, and its protein has been shown to influence SCN2A by altering channel properties and shifting the voltage dependence of activation in the hyperpolarizing direction.<xref ref-type="ref" rid="epi412057-bib-0029">29</xref> Variants in the <italic>SCN2A</italic> gene are a well‐known cause of benign familial neonatal and infantile seizures<xref ref-type="ref" rid="epi412057-bib-0005">5</xref> and early infantile epileptic encephalopathy.<xref ref-type="ref" rid="epi412057-bib-0030">30</xref> Haploinsufficiency of <italic>SCN4B</italic> may cause epilepsy indirectly by influencing SCN2A function.</p>
<p>Last, the <italic>NRXN3</italic> gene (MIM 600567) was deleted in two unrelated children in our cohort. We had described one of them in a previous study: she (Patient 337) has a severe developmental delay and a concomitant deletion of <italic>NRXN1</italic> with no second <italic>NRXN1</italic> sequence variant on the other allele.<xref ref-type="ref" rid="epi412057-bib-0031">31</xref>
<italic>NRXN3</italic> encodes a polymorphic cell surface protein, neurexin III, that is expressed in neurons and is necessary for neurotransmission. Deletions and variants in the neurexin I gene, <italic>NRXN1,</italic> have been associated with moderate to severe intellectual disability, language delay, autism spectrum disorder, and seizures.<xref ref-type="ref" rid="epi412057-bib-0031">31</xref> The severe phenotype of our patient was not in line with the milder phenotypes previously reported in children with heterozygous <italic>NRXN1</italic> deletions so far, and we speculated that her severe phenotype might be explained by the additional deletion of <italic>NRXN3</italic>.<xref ref-type="ref" rid="epi412057-bib-0031">31</xref> In the current study, we found a second <italic>NRXN3</italic> deletion in another unrelated child with symptomatic focal epilepsy and a pervasive developmental disorder not otherwise specified (Table <xref ref-type="table" rid="epi412057-tbl-0002">2</xref>). <italic>NRXN3</italic> has been associated with bipolar disorder<xref ref-type="ref" rid="epi412057-bib-0032">32</xref> and autism spectrum disorder.<xref ref-type="ref" rid="epi412057-bib-0033">33</xref> Recently, <italic>NRXN3</italic> deletions were reported in four individuals of three different families with epilepsy (unclassified in three, progressive myoclonic epilepsy in one), behavioral problems and developmental delay, or intellectual disability.<xref ref-type="ref" rid="epi412057-bib-0010">10</xref> The observation of <italic>NRXN3</italic> deletions in two children in our cohort supports the idea that <italic>NRXN3</italic> haploinsufficiency can be associated with epilepsy.</p>
<p>For all four candidate genes, <italic>MYT1L, UNC5D, SCN4B,</italic> and <italic>NRXN3</italic>, additional patients with compatible genotypes and phenotypes, and/or supporting evidence from functional studies, are needed to confirm their role in the pathophysiology of epilepsy.</p>
<p>In eight different regions, we found CNVs that occurred 10 times more often in our study cohort than in healthy controls. The pathogenicity of these CNVs in epilepsy is doubtful because these children either had other identified epilepsy causes and/or the CNVs lacked genes of interest for epilepsy.</p>
</sec>
</sec>
<sec id="epi412057-sec-0018">
<title>Conclusion</title>
<p>Our study demonstrates the importance of microarray analysis in the diagnostic work‐up of epilepsy in childhood. We identified known clinically relevant CNVs for epilepsy in 11% of the children investigated. This yield was obviously influenced by the clinical selection of children, which was largely based on the presence of additional developmental or behavioral problems and/or facial dysmorphisms. Furthermore, we identified novel CNVs that include four new candidate genes for epilepsy: <italic>MYT1L, UNC5D, SCN4B</italic> and <italic>NRXN3</italic>. Analysis of these genes in larger study cohorts is warranted to further confirm their role in the etiology of epilepsy.</p>
</sec>
<sec id="epi412057-sec-0020">
<title>Disclosure</title>
<p>None of the authors has any conflicts of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p>
</sec>
<sec id="epi412057-sec-0021">
<title>Linking to Databases</title>
<p>
<ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/">UCSC Genome Bioinformatics</ext-link>
</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">DatabaseE of genomiC varIation and Phenotype in Humans using Ensembl Resources (DECIPHER)</ext-link>
</p>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.omim.org/">Online Mendelian Inheritance in Man (OMIM)</ext-link>
</p>
<p>
<ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/">Database of Genomic Variants (DGV)</ext-link>
</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="epi412057-sup-0001">
<caption>
<p>
<bold>Figure S1.</bold> Overview of chromosome 8q22 deletions.</p>
</caption>
<media xlink:href="EPI4-2-244-s001.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="epi412057-sup-0002">
<caption>
<p>
<bold>Table S1.</bold> Information on novel candidate genes.</p>
</caption>
<media xlink:href="EPI4-2-244-s002.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="epi412057-sup-0003">
<caption>
<p>
<bold>Table S2.</bold> CNVs with a 10 times higher frequency in the study cohort compared to controls.</p>
</caption>
<media xlink:href="EPI4-2-244-s003.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="epi412057-sec-0019">
<title>Acknowledgments</title>
<p>P. M. C. C. received an unrestricted research grant from UCB Pharma BV, Belgium. UCB Pharma BV had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank K. McIntyre for editing the manuscript and J. Anderson for help identifying CNVs for epilepsy reported in the literature.</p>
</ack>
<bio id="epi412057-biog-0001">
<p>
<bold>Danique R. M. Vlaskamp, MD</bold>, is a PhD student in epilepsy genetics at the University Medical Center Groningen.</p>
<graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="EPI4-2-244-g002.gif"></graphic>
</bio>
<ref-list content-type="cited-references" id="epi412057-bibl-0001">
<title>References</title>
<ref id="epi412057-bib-0001">
<label>1</label>
<mixed-citation id="epi412057-cit-0001" publication-type="journal">
<string-name>
<surname>Thomas</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>. <article-title>The hidden genetics of epilepsy—a clinically important new paradigm</article-title>. <source xml:lang="en"/>Nat Rev Neurol
<year>2014</year>;<volume>10</volume>:<fpage>283</fpage>–<lpage>292</lpage>.<pub-id pub-id-type="pmid">24733163</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0002">
<label>2</label>
<mixed-citation id="epi412057-cit-0002" publication-type="journal">
<string-name>
<surname>Myers</surname>
<given-names>CT</given-names>
</string-name>, <string-name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</string-name>. <article-title>Advancing epilepsy genetics in the genomic era</article-title>. <source xml:lang="en"/>Genome Med
<year>2015</year>;<volume>7</volume>:<fpage>91</fpage>.<pub-id pub-id-type="pmid">26302787</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0003">
<label>3</label>
<mixed-citation id="epi412057-cit-0003" publication-type="journal">
<string-name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Wiszniewska</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Copy number and SNP arrays in clinical diagnostics</article-title>. <source xml:lang="en"/>Annu Rev Genomics Hum Genet
<year>2011</year>;<volume>12</volume>:<fpage>25</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">21801020</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0004">
<label>4</label>
<mixed-citation id="epi412057-cit-0004" publication-type="journal">
<string-name>
<surname>Heron</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Grinton</surname>
<given-names>BE</given-names>
</string-name>, et al. <article-title>Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures</article-title>. <source xml:lang="en"/>J Med Genet
<year>2007</year>;<volume>44</volume>:<fpage>791</fpage>–<lpage>796</lpage>.<pub-id pub-id-type="pmid">17675531</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0005">
<label>5</label>
<mixed-citation id="epi412057-cit-0005" publication-type="journal">
<string-name>
<surname>Zara</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Specchio</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Striano</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance</article-title>. <source xml:lang="en"/>Epilepsia
<year>2013</year>;<volume>54</volume>:<fpage>425</fpage>–<lpage>436</lpage>.<pub-id pub-id-type="pmid">23360469</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0006">
<label>6</label>
<mixed-citation id="epi412057-cit-0006" publication-type="journal">
<string-name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Muhle</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ostertag</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Genome‐wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies</article-title>. <source xml:lang="en"/>PLoS Genet
<year>2010</year>;<volume>6</volume>:<fpage>e1000962</fpage>.<pub-id pub-id-type="pmid">20502679</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0007">
<label>7</label>
<mixed-citation id="epi412057-cit-0007" publication-type="journal">
<string-name>
<surname>de Kovel</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Trucks</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Helbig</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies</article-title>. <source xml:lang="en"/>Brain
<year>2010</year>;<volume>133</volume>:<fpage>23</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">19843651</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0008">
<label>8</label>
<mixed-citation id="epi412057-cit-0008" publication-type="journal">
<string-name>
<surname>Jahn</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>von Spiczak</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Muhle</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Iterative phenotyping of 15q11.2, 15q13.3 and 16p13.11 microdeletion carriers in pediatric epilepsies</article-title>. <source xml:lang="en"/>Epilepsy Res
<year>2014</year>;<volume>108</volume>:<fpage>109</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">24246141</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0009">
<label>9</label>
<mixed-citation id="epi412057-cit-0009" publication-type="journal">
<string-name>
<surname>Olson</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Avallone</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Copy number variation plays an important role in clinical epilepsy</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2014</year>;<volume>75</volume>:<fpage>943</fpage>–<lpage>958</lpage>.<pub-id pub-id-type="pmid">24811917</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0010">
<label>10</label>
<mixed-citation id="epi412057-cit-0010" publication-type="journal">
<string-name>
<surname>Faheem</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Naseer</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Chaudhary</surname>
<given-names>AG</given-names>
</string-name>, et al. <article-title>Array‐comparative genomic hybridization analysis of a cohort of Saudi patients with epilepsy</article-title>. <source xml:lang="en"/>CNS Neurol Disord Drug Targets
<year>2015</year>;<volume>14</volume>:<fpage>468</fpage>–<lpage>475</lpage>.<pub-id pub-id-type="pmid">25921748</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0011">
<label>11</label>
<mixed-citation id="epi412057-cit-0011" publication-type="journal">
<string-name>
<surname>Naseer</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Faheem</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chaudhary</surname>
<given-names>AG</given-names>
</string-name>, et al. <article-title>Genome wide analysis of novel copy number variations duplications/deletions of different epileptic patients in Saudi Arabia</article-title>. <source xml:lang="en"/>BMC Genom
<year>2015</year>;<volume>16</volume>(<issue>Suppl 1</issue>):<fpage>S10</fpage>.</mixed-citation>
</ref>
<ref id="epi412057-bib-0012">
<label>12</label>
<mixed-citation id="epi412057-cit-0012" publication-type="journal">
<string-name>
<surname>Fisher</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Acevedo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Arzimanoglou</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>ILAE official report: a practical clinical definition of epilepsy</article-title>. <source xml:lang="en"/>Epilepsia
<year>2014</year>;<volume>55</volume>:<fpage>475</fpage>–<lpage>482</lpage>.<pub-id pub-id-type="pmid">24730690</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0013">
<label>13</label>
<mixed-citation id="epi412057-cit-0013" publication-type="journal">
<string-name>
<surname>Engel</surname>
<given-names>J</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Report of the ILAE classification core group</article-title>. <source xml:lang="en"/>Epilepsia
<year>2006</year>;<volume>47</volume>:<fpage>1558</fpage>–<lpage>1568</lpage>.<pub-id pub-id-type="pmid">16981873</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0014">
<label>14</label>
<mixed-citation id="epi412057-cit-0014" publication-type="journal">
<string-name>
<surname>MacDonald</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Ziman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yuen</surname>
<given-names>RK</given-names>
</string-name>, et al. <article-title>The database of genomic variants: a curated collection of structural variation in the human genome</article-title>. <source xml:lang="en"/>Nucleic Acids Res
<year>2014</year>;<volume>42</volume>:<fpage>D986</fpage>–<lpage>D992</lpage>.<pub-id pub-id-type="pmid">24174537</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0015">
<label>15</label>
<mixed-citation id="epi412057-cit-0015" publication-type="journal">
<string-name>
<surname>Hanemaaijer</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dijkhuizen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Haadsma</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>A 649 kb microduplication in 1p34.1, including POMGNT1, in a patient with microcephaly, coloboma and laryngomalacia; and a review of the literature</article-title>. <source xml:lang="en"/>Eur J Med Genet
<year>2009</year>;<volume>52</volume>:<fpage>116</fpage>–<lpage>119</lpage>.<pub-id pub-id-type="pmid">19452620</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0016">
<label>16</label>
<mixed-citation id="epi412057-cit-0016" publication-type="journal">
<string-name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Buysse</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Clayton‐Smith</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Five patients with novel overlapping interstitial deletions in 8q22.2q22.3</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2011</year>;<volume>155A</volume>:<fpage>1857</fpage>–<lpage>1864</lpage>.<pub-id pub-id-type="pmid">21739578</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0017">
<label>17</label>
<mixed-citation id="epi412057-cit-0017" publication-type="journal">
<string-name>
<surname>Kuroda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ohashi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Refinement of the deletion in 8q22.2‐q22.3: the minimum deletion size at 8q22.3 related to intellectual disability and epilepsy</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2014</year>;<volume>164A</volume>:<fpage>2104</fpage>–<lpage>2108</lpage>.<pub-id pub-id-type="pmid">24801133</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0018">
<label>18</label>
<mixed-citation id="epi412057-cit-0018" publication-type="journal">
<string-name>
<surname>Mercimek‐Mahmutoglu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cordeiro</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Diagnostic yield of genetic testing in epileptic encephalopathy in childhood</article-title>. <source xml:lang="en"/>Epilepsia
<year>2015</year>;<volume>56</volume>:<fpage>707</fpage>–<lpage>716</lpage>.<pub-id pub-id-type="pmid">25818041</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0019">
<label>19</label>
<mixed-citation id="epi412057-cit-0019" publication-type="journal">
<string-name>
<surname>Shinawi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Bhatt</surname>
<given-names>SS</given-names>
</string-name>, et al. <article-title>A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes</article-title>. <source xml:lang="en"/>Nat Genet
<year>2009</year>;<volume>41</volume>:<fpage>1269</fpage>–<lpage>1271</lpage>.<pub-id pub-id-type="pmid">19898479</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0020">
<label>20</label>
<mixed-citation id="epi412057-cit-0020" publication-type="journal">
<string-name>
<surname>Helbig</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Sharp</surname>
<given-names>AJ</given-names>
</string-name>, et al. <article-title>15q13.3 microdeletions increase risk of idiopathic generalized epilepsy</article-title>. <source xml:lang="en"/>Nat Genet
<year>2009</year>;<volume>41</volume>:<fpage>160</fpage>–<lpage>162</lpage>.<pub-id pub-id-type="pmid">19136953</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0021">
<label>21</label>
<mixed-citation id="epi412057-cit-0021" publication-type="journal">
<string-name>
<surname>Moreira</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Griesi‐Oliveira</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bossolani‐Martins</surname>
<given-names>AL</given-names>
</string-name>, et al. <article-title>Investigation of 15q11‐q13, 16p11.2 and 22q13 CNVs in autism spectrum disorder in Brazilian individuals with and without epilepsy</article-title>. <source xml:lang="en"/>PLoS One
<year>2014</year>;<volume>9</volume>:<fpage>e107705</fpage>.<pub-id pub-id-type="pmid">25255310</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0022">
<label>22</label>
<mixed-citation id="epi412057-cit-0022" publication-type="journal">
<string-name>
<surname>Pang</surname>
<given-names>ZP</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Vierbuchen</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Induction of human neuronal cells by defined transcription factors</article-title>. <source xml:lang="en"/>Nature
<year>2011</year>;<volume>476</volume>:<fpage>220</fpage>–<lpage>223</lpage>.<pub-id pub-id-type="pmid">21617644</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0023">
<label>23</label>
<mixed-citation id="epi412057-cit-0023" publication-type="journal">
<string-name>
<surname>Stevens</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>van Ravenswaaij‐Arts</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Janssen</surname>
<given-names>JW</given-names>
</string-name>, et al. <article-title>MYT1L is a candidate gene for intellectual disability in patients with 2p25.3 (2pter) deletions</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2011</year>;<volume>155A</volume>:<fpage>2739</fpage>–<lpage>2745</lpage>.<pub-id pub-id-type="pmid">21990140</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0024">
<label>24</label>
<mixed-citation id="epi412057-cit-0024" publication-type="journal">
<string-name>
<surname>De Rocker</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Vergult</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Koolen</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity</article-title>. <source xml:lang="en"/>Genet Med
<year>2015</year>;<volume>17</volume>:<fpage>460</fpage>–<lpage>466</lpage>.<pub-id pub-id-type="pmid">25232846</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0025">
<label>25</label>
<mixed-citation id="epi412057-cit-0025" publication-type="journal">
<string-name>
<surname>Mayo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rosello</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Monfort</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Haploinsufficiency of the MYT1L gene causes intellectual disability frequently associated with behavioral disorder</article-title>. <source xml:lang="en"/>Genet Med
<year>2015</year>;<volume>17</volume>:<fpage>683</fpage>–<lpage>684</lpage>.<pub-id pub-id-type="pmid">26240977</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0026">
<label>26</label>
<mixed-citation id="epi412057-cit-0026" publication-type="journal">
<string-name>
<surname>Sasaki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tabata</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tachikawa</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>The cortical subventricular zone‐specific molecule Svet1 is part of the nuclear RNA coded by the putative netrin receptor gene Unc5d and is expressed in multipolar migrating cells</article-title>. <source xml:lang="en"/>Mol Cell Neurosci
<year>2008</year>;<volume>38</volume>:<fpage>474</fpage>–<lpage>483</lpage>.<pub-id pub-id-type="pmid">18547816</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0027">
<label>27</label>
<mixed-citation id="epi412057-cit-0027" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Unc5D regulates p53‐dependent apoptosis in neuroblastoma cells</article-title>. <source xml:lang="en"/>Mol Med Rep
<year>2014</year>;<volume>9</volume>:<fpage>2411</fpage>–<lpage>2416</lpage>.<pub-id pub-id-type="pmid">24691657</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0028">
<label>28</label>
<mixed-citation id="epi412057-cit-0028" publication-type="journal">
<string-name>
<surname>Utami</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Hillmer</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Aksoy</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Detection of chromosomal breakpoints in patients with developmental delay and speech disorders</article-title>. <source xml:lang="en"/>PLoS One
<year>2014</year>;<volume>9</volume>:<fpage>e90852</fpage>.<pub-id pub-id-type="pmid">24603971</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0029">
<label>29</label>
<mixed-citation id="epi412057-cit-0029" publication-type="journal">
<string-name>
<surname>Yu</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Westenbroek</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Silos‐Santiago</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Sodium channel beta4, a new disulfide‐linked auxiliary subunit with similarity to beta2</article-title>. <source xml:lang="en"/>J Neurosci
<year>2003</year>;<volume>23</volume>:<fpage>7577</fpage>–<lpage>7585</lpage>.<pub-id pub-id-type="pmid">12930796</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0030">
<label>30</label>
<mixed-citation id="epi412057-cit-0030" publication-type="journal">
<string-name>
<surname>Ogiwara</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sawaishi</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>De novo mutations of voltage‐gated sodium channel alphaII gene SCN2A in intractable epilepsies</article-title>. <source xml:lang="en"/>Neurology
<year>2009</year>;<volume>73</volume>:<fpage>1046</fpage>–<lpage>1053</lpage>.<pub-id pub-id-type="pmid">19786696</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0031">
<label>31</label>
<mixed-citation id="epi412057-cit-0031" publication-type="journal">
<string-name>
<surname>Bena</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bruno</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature</article-title>. <source xml:lang="en"/>Am J Med Genet B Neuropsychiatr Genet
<year>2013</year>;<volume>162B</volume>:<fpage>388</fpage>–<lpage>403</lpage>.<pub-id pub-id-type="pmid">23533028</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0032">
<label>32</label>
<mixed-citation id="epi412057-cit-0032" publication-type="journal">
<string-name>
<surname>Noor</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Cohen‐Woods</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes</article-title>. <source xml:lang="en"/>Am J Med Genet B Neuropsychiatr Genet
<year>2014</year>;<volume>165B</volume>:<fpage>303</fpage>–<lpage>313</lpage>.<pub-id pub-id-type="pmid">24700553</pub-id></mixed-citation>
</ref>
<ref id="epi412057-bib-0033">
<label>33</label>
<mixed-citation id="epi412057-cit-0033" publication-type="journal">
<string-name>
<surname>Vaags</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Rare deletions at the neurexin 3 locus in autism spectrum disorder</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2012</year>;<volume>90</volume>:<fpage>133</fpage>–<lpage>141</lpage>.<pub-id pub-id-type="pmid">22209245</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>